<code id='6B2412A386'></code><style id='6B2412A386'></style>
    • <acronym id='6B2412A386'></acronym>
      <center id='6B2412A386'><center id='6B2412A386'><tfoot id='6B2412A386'></tfoot></center><abbr id='6B2412A386'><dir id='6B2412A386'><tfoot id='6B2412A386'></tfoot><noframes id='6B2412A386'>

    • <optgroup id='6B2412A386'><strike id='6B2412A386'><sup id='6B2412A386'></sup></strike><code id='6B2412A386'></code></optgroup>
        1. <b id='6B2412A386'><label id='6B2412A386'><select id='6B2412A386'><dt id='6B2412A386'><span id='6B2412A386'></span></dt></select></label></b><u id='6B2412A386'></u>
          <i id='6B2412A386'><strike id='6B2412A386'><tt id='6B2412A386'><pre id='6B2412A386'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:76

          Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

          advertisement

          For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          FDA approves potent Eli Lilly obesity drug, Zepbound
          FDA approves potent Eli Lilly obesity drug, Zepbound

          DarronCummings/APEliLilly’sblockbusterdrugtirzepatide,soldasMounjarofortype2diabetes,hasbeenclearedt

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Biden tests positive for Covid

          PresidentJoeBidenremoveshisfacemaskashearrivestospeakduringameetingwithCEOsintheWhiteHousecomplexThu